About Contact Us Careers
Sign In

Contraceptives Market Size & Share, by Product Type (Drugs, Devices, Condoms, Vaginal Rings, Implants, Injectables); Age (15-44 Years, Above 44 Years); Gender (Male, Female); End-user (Homecare, Clinics, Hospitals, Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4635
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Contraceptives Landscape

top-features-companies
    • Novartis Pharmaceutical Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agile Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Piramal Group
    • Viatris Inc.
    • Pfizer Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Perrigo Company plc declared that HRA Pharma submitted its application to U.S. FDA for ‘Opill’, a progestin-only daily birth control pill that would be the first OTC birth control pill in the United States.

  • United States Food and Drug Administration (U.S FDA) approved permission for ‘Natural Cycles’, the first mobile application for contraception to prevent unwanted pregnancy. The app predicts the woman’s fertile days and menstrual cycles based on body temperature.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4635
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing disposable income and rising world population along with elevating risks of abortion are the major factors driving the growth of the contraceptives market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Lack of social acceptance and side effects occurrence such as nausea, headache along with lack of social acceptance are estimated to be the growth-hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, age, gender, end-user, and by region.

The pharmacies segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying